• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Nrx Pharmaceuticals Inc (NQ: NRXP )

    1.310 +0.040 (+3.15%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 6, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 67,409
    Open 1.270
    Bid (Size) 1.260 (1)
    Ask (Size) 1.310 (10)
    Prev. Close 1.270
    Today's Range 1.250 - 1.320
    52wk Range 1.100 - 7.333
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    HOPE Therapeutics Secures Financing For Ketamine Clinic Expansion
    HOPE Therapeutics, Inc., a subsidiary of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP), 
    Via Benzinga
    Plans for New Acquisition of Clinics Generating $100 Million to Complement Progress on Accelerated Drug Approval for Bipolar Depression and Related Disorders: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
    Via Get News
    Topics Regulatory Compliance
    Exposures Legal Regulatory

    Performance

    YTD
    -73.75%
    -73.75%
    1 Month
    -12.67%
    -12.67%
    3 Month
    -35.15%
    -35.15%
    6 Month
    -53.38%
    -53.38%
    1 Year
    -62.00%
    -62.00%

    More News

    Read More
    Substantial Funding, Debt Resolution, HOPE Dividend, Successful Clinical Trial Towards Accelerated Drug Approval for Bipolar Depression: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
    Via Get News
    Topics Regulatory Compliance Retirement
    Exposures Legal Pension Regulatory
    NRXP Stock Earnings: NRX Pharmaceuticals Misses EPS for Q2 2024
    Via InvestorPlace
    Alignment with FDA on Pediatric Study Plan and Accelerated Approval to Treat Bipolar Depression and Akathisia: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
    Via Get News
    Exposures Product Safety
    Accelerated Approval to Treat Bipolar Depression and Akathisia Could Yield Over $150 in Revenue Per Share; Planned HOPE Subsidiary Spinoff to Continue: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
    Via Get News
    Substantial Funding, Debt Resolution, HOPE Dividend, Successful Clinical Trial Towards Accelerated Drug Approval for Bipolar Depression: Nasdaq: NRXP
    Via PRLog
    Topics Regulatory Compliance
    Exposures Legal Product Safety Regulatory
    NRx Pharmaceuticals Highlights Breakthrough Oral Antidepressant’s Efficacy in Reducing Suicidality in Bipolar Depression at ASCP June 2024 Meeting: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
    Via Get News
    First Oral Antidepressant Clinically Demonstrated to Reduce Suicidality in Bipolar Depression with Data Supporting Accelerated Approval Process: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
    Via Get News
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    NRXP Stock Earnings: NRX Pharmaceuticals Misses EPS for Q1 2024
    Via InvestorPlace
    NRx Pharmaceuticals Eyes First Commercial Revenue in 2024, Announces Breakthroughs in Bi-Annual Milestone Update
    Via ACCESSWIRE
    Final Clinical Trial Results Show Superior Safety and Efficacy for NRX-101; Plans to Seek Accelerated Approval for Bipolar Depression and Schizophrenia: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
    Via Get News
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Gold Down Over 2%; 3M Profit Beats Expectations
    Via Benzinga
    Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Why Is NRx Pharmaceuticals Stock Falling After Data From Suicidal Bipolar Depression Study
    Via Benzinga
    InvestorNewsBreaks – NRx Pharmaceuticals Inc. Releases Pricing of Public Offering, Expected to Result in Estimated $2M
    Via Investor Brand Network
    Exposures Product Safety
    Nasdaq Down 0.5%; Lithium Americas Shares Slide
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Crude Oil Edges Lower; Bio-Path Holdings Shares Spike Higher
    Via Benzinga
    Exposures Fossil Fuels
    Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.